INGN Q1 2025 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$82M+5.5% YoY

Gross Profit

$36M44.2% margin

Operating Income

-$8M-9.3% margin

Net Income

-$6M-7.5% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$308M

Total Liabilities

$110M

Stockholders' Equity

$198M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$78M	+5.5%
Gross Profit	$36M	$34M	+5.8%
Operating Income	-$8M	-$16M	+53.0%
Net Income	-$6M	-$15M	+57.6%

Geographic Segments

UNITED STATES

$50M61%

Non-US

$32M39%